US regulation of plant-made biopharmaceuticals - Part 1

被引：0
|
作者：
Berberich, SA [1 ]
Devine, RA [1 ]
机构：
[1] Chloren Inc, Licensing & Dev, St Louis, MO 63141 USA
来源：
BIOPHARM INTERNATIONAL | 2005年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The evaluation, production, and distribution of therapeutic products derived from recombinant plants are regulated under existing laws administered by FDA, USDA, and EPA.
引用
收藏
页码：38 / +
页数：7
相关论文
共 50 条
  • [1] US regulation of plant-made biopharmaceuticals - Part 2
    Berberich, SA
    Devine, RA
    BIOPHARM INTERNATIONAL, 2005, 18 (02) : 68 - 71
  • [2] Plant-made vaccine antigens and biopharmaceuticals
    Daniell, Henry
    Singh, Nameirakpam D.
    Mason, Hugh
    Streatfield, Stephen J.
    TRENDS IN PLANT SCIENCE, 2009, 14 (12) : 669 - 679
  • [3] Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies
    Rosales-Mendoza, Sergio
    MOLECULAR BIOTECHNOLOGY, 2015, 57 (10) : 869 - 879
  • [4] Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies
    Sergio Rosales-Mendoza
    Molecular Biotechnology, 2015, 57 : 869 - 879
  • [5] Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals
    Arevalo-Villalobos, Jaime I.
    Rosales-Mendoza, Sergio
    Zarazua, Sergio
    EXPERT REVIEW OF VACCINES, 2017, 16 (02) : 151 - 159
  • [6] Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
    Rosales-Mendoza, Sergio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 545 - 548
  • [7] Plant-made therapeutics
    Winder, Robert
    Chemistry and Industry (London), 2003, (20): : 16 - 18
  • [8] Plant-Made Biologics
    Chen, Qiang
    Santi, Luca
    Zhang, Chenming
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [9] Plant-made therapeutics
    Winder, R
    CHEMISTRY & INDUSTRY, 2003, (20) : 16 - 18
  • [10] Plant-made pharmaceuticals
    Wagner, S
    BIOPHARM INTERNATIONAL, 2004, 17 (08) : 74 - 74
12345